Endothelial Cells Lining Sporadic Cerebral Cavernous Malformation Cavernomas Undergo Endothelial-to-Mesenchymal Transition
Author(s) -
Luca Bravi,
Matteo Malinverno,
Federica Pisati,
Noemi Rudini,
Roberto Cuttano,
Roberto Pallini,
Maurizio Martini,
Luigi Maria Larocca,
Marco Locatelli,
Vincenzo Levi,
Giulio Bertani,
Elisabetta Dejana,
Maria Grazia Lampugnani
Publication year - 2016
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.115.011867
Subject(s) - medicine , pathology , mesenchymal stem cell , phenotype , vascular malformation , epithelial–mesenchymal transition , immunohistochemistry , endothelial stem cell , central nervous system , mutation , transition (genetics) , cancer research , gene , biology , genetics , in vitro , surgery
Cerebral cavernous malformation (CCM) is characterized by multiple lumen vascular malformations in the central nervous system that can cause neurological symptoms and brain hemorrhages. About 20% of CCM patients have an inherited form of the disease with ubiquitous loss-of-function mutation in any one of 3 genes CCM1, CCM2, and CCM3. The rest of patients develop sporadic vascular lesions histologically similar to those of the inherited form and likely mediated by a biallelic acquired mutation of CCM genes in the brain vasculature. However, the molecular phenotypic features of endothelial cells in CCM lesions in sporadic patients are still poorly described. This information is crucial for a targeted therapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom